Radiation-induced coronary artery disease in young patients

Autor: Christina Rodriguez Ruiz, Marcel Mesa-Pabón, Katherine Soto, José Hernández Román, Angel López-Candales

Publikováno v: Heart Views, Vol 19, Iss 1, Pp 23-26 (2018)

Exposure to radiotherapy has been shown to accelerate myocardial damage or injury to the cardiac vasculature. Accelerated coronary artery disease (CAD) is one of the main manifestations of cardiac disease in patients who undergo mediastinal radiation

Externí odkaz: https://doaj.org/article/9ca51c62b83a43d3876b6572dbc45933

A real life use of ruxolitinib in patients with acute and chronic graft versus host disease refractory to corticosteroid treatment in Latin American patients

Autor: Pablo Uribe, Veronica Jara, Jaime Pereira, Katherine Soto, Pablo Bertin, Mauricio Ocqueteau, Mauricio Sarmiento

Publikováno v: Hematology, Transfusion and Cell Therapy, Volume: 43, Issue: 3, Pages: 303-308, Published: 18 OCT 2021
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 3, Pp 303-308 (2021)

Introduction: Graft-versus-host disease (GVHD) is a serious complication in allogeneic transplantation. The first-line treatment is high doses of corticosteroids. In the absence of response to corticosteroids, several immunosuppressive drugs can be u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53cc6ce35dad4b9950cfb3a23e15261b
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792021000300303&lng=en&tlng=en

[Age does not affect the outcome of allogeneic hematopoietic precursor transplantation for acute myeloid leukemia]

Autor: Mauricio, Sarmiento, Patricio, Rojas, Nicolás, Triantafilo, James, Campbell, María José, García, Mauricio, Ocqueteau, Vicente, Sandoval, Andrés, Rojas, José Tomás, Gazmuri, Gonzalo, Guerrero, Maximiliano, Vergara, Pablo, Bertin, Pablo, Ramírez, Verónica, Jara, Catherine, Gutiérrez, Katherine, Soto, Silvana, Arellano, Isabel, Pizarro, Carla, Lorca

Publikováno v: Revista medica de Chile. 149(1)

In our country, transplantation centers differ in the age limit for allogeneic hematopoietic transplantation (ALOHT). In our program, transplants with age- adjusted conditioning are performed in patients until 70 years old. Currently more than 60% of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::86244f52c148bbecce7ba60768505ba1
https://pubmed.ncbi.nlm.nih.gov/34106132

Excelente respuesta a tratamiento con ABVD en pacientes con linfoma de Hodgkin localizado

Autor: Daniel Ernst, Katherine Soto, Javier Díaz

Publikováno v: Revista médica de Chile v.145 n.5 2017
SciELO Chile
CONICYT Chile
instacron:CONICYT

Background: Recent trials show that > 90% of patients with early stage Hodgkin`s Lymphoma (ESHL) can be cured, especially when using the ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapeutic (CT) protocol. The use of radiothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30042f0c7ca3e503526b89c878d41233
https://doi.org/10.4067/s0034-98872017000500009

[Cytarabine and hematopoietic cell transplantation for mantle cell lymphoma. Analysis of 20 patients]

Autor: James, Campbell, Sebastián, Hurtado, Consuelo, Kutz, Katherine, Soto, Daniel, Ernst

Publikováno v: Revista medica de Chile. 147(1)

Mantle cell lymphoma (MCL) has high relapse and mortality rates. There is a survival benefit when treatment is intensified with cytarabine (AraC), hematopoietic cell transplantation (HCT) and maintenance with rituximab.To assess the outcomes of patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d145a337c37c587adda4c1c39168ad18
https://pubmed.ncbi.nlm.nih.gov/30848759